Patient 1 | Patient 2 | Patient 3 | Patient 4 | |||||
---|---|---|---|---|---|---|---|---|
MII-pH monitoring before treatment with prucalopride | Medication during monitoring: | Medication during monitoring: | Medication during monitoring: | Medication during monitoring: | ||||
- Ranitidine 75mg per day | - Pantoprazole 40mg per day | - Omeprazole 20mg per day | - none | |||||
Acid reflux time: | 1.5% | Acid reflux time: | 0.3% | Acid reflux time: | 0.1% | Acid reflux time: | 2.8% | |
Overall reflux episodes: | 128 | Overall reflux episodes: | 143 | Overall reflux episodes: | 96 | Overall reflux episodes: | 108 | |
Mixed or liquid reflux episodes: | 94 | Mixed or liquid reflux episodes: | 140 | Mixed or liquid reflux episodes: | 79 | Mixed or liquid reflux episodes: | 104 | |
Gaseous reflux episodes: | 34 | Gaseous reflux episodes: | 3 | Gaseous reflux episodes: | 17 | Gaseous reflux episodes: | 4 | |
Acid reflux episodes: | 84 | Acid reflux episodes: | 15 | Acid reflux episodes: | 17 | Acid reflux episodes: | 71 | |
Non- and/or weakly acid reflux episodes: | 44 | Non- and/or weakly acid reflux episodes: | 128 | Non- and/or weakly acid reflux episodes: | 79 | Non- and/or weakly acid reflux episodes: | 37 | |
*Scale 0 to 10: 0 = none; 10 = unbearable | Subjective symptom scores* | Subjective symptom scores* | Subjective symptom scores* | Subjective symptom scores* | ||||
- Heartburn + Regurgitation: 5 | - Heartburn + Regurgitation: 7 | - Regurgitation: 5 | - Heartburn, Globus, Bloating: 9 | |||||
- Limitation of daily life: 5 | - Limitation of daily life: 6 | - Limitation of daily life: 5 | - Limitation of daily life: 9 | |||||
SI: positive for heartburn and regurgitation | SI: positive for heartburn and regurgitation | SI: positive for regurgitation | SI: positive for heartburn, globus and bloating |